Your browser doesn't support javascript.
loading
The pivotal regulatory factor circBRWD1 inhibits arsenic exposure-induced lung cancer occurrence by binding mRNA and regulating its stability.
Li, Xiaofei; Chen, Sixian; Wang, Xin; Zhang, Ruirui; Yang, Jialei; Xu, Haotian; He, Wanting; Lai, Mingshuang; Wu, Shuilian; Nan, Aruo.
Afiliación
  • Li X; Department of Toxicology, School of Public Health, Guangxi Medical University, Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Nanning 530021, China.
  • Chen S; Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning 530021, China.
  • Wang X; Guangxi Key Laboratory of Environment and Health Research, Guangxi Medical University, Nanning 530021, China.
  • Zhang R; Department of Toxicology, School of Public Health, Guangxi Medical University, Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Nanning 530021, China.
  • Yang J; Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning 530021, China.
  • Xu H; Guangxi Key Laboratory of Environment and Health Research, Guangxi Medical University, Nanning 530021, China.
  • He W; Zhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  • Lai M; Department of Toxicology, School of Public Health, Guangxi Medical University, Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Nanning 530021, China.
  • Wu S; Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning 530021, China.
  • Nan A; Guangxi Key Laboratory of Environment and Health Research, Guangxi Medical University, Nanning 530021, China.
Mol Ther Oncolytics ; 26: 399-412, 2022 Sep 15.
Article en En | MEDLINE | ID: mdl-36159776
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Año: 2022 Tipo del documento: Article País de afiliación: China